Skip to content

Study for the effectiveness and standardization of acupuncturing Qugu (CV2) in the targeting treatment of benign prostatic hyperplasia (BPH)under CT localization

Study for the effectiveness and standardization of acupuncturing Qugu (CV2) in the targeting treatment of benign prostatic hyperplasia (BPH)under CT localization

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029203
Enrollment
Unknown
Registered
2020-01-18
Start date
2020-02-15
Completion date
Unknown
Last updated
2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Interventions

Experimental group 1:Acupuncture the Qugu (CV2) point to reach the prostate gland
Experimental group 2:Acupuncture the Qugu (CV2) point with the needle tip 1cm from the prostate gland
Control group:Inserting the blunt needle through the retainer pad to reach the skin surface, twist 3 times without piercing the skin

Sponsors

Xiyuan Hospital, Chinese Academy of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. In accordance with the diagnostic criteria of BPH, and the diagnosis was confirmed by a specialist; 2. Aged 50 to 80 years old; 3. Those who sign informed consent voluntarily shall volunteer for the examination.

Exclusion criteria

Exclusion criteria: 1. Unable to communicate; 2. With urethritis, acute prostatitis, urinary calculi and other diseases; 3. Neurogenic bladder, bladder neck fibrosis, urethral stricture and other diseases; 4. Those with neurological diseases and diabetes history affected urination function; 5. Prostatic hyperplasia complicated with prostate cancer,tuberculosis and other malignant consumptive disease; 6. patients with liver, kidney insufficiency and other cardiopulmonary diseases, blood diseases and other serious diseases; 7. patients with hydronephrosis in the upper urinary tract found by B-ultrasonics and impaired renal function; 8. patients using drugs that may affect bladder function or are receiving BPH drugs; 9. Hyperplasia of prostate gland was too large under B ultrasonic or CT which protrude into the bladder too much and influence the operation of acupuncture; 10. B ultrasonic or CT found bladder residual urine over 100 ml affecting the acupuncture operation.

Design outcomes

Primary

MeasureTime frame
International Prostate Symptom Score (IPSS);scoring of symptoms and signs and auxiliary examination;

Secondary

MeasureTime frame
age;nationality;educational level;profession;height;Hip circumference at the level of pubic symphysis;Quality of Life(QoL);The correlation between clinical efficacy and traditional Chinese medicine syndrome type;safety evaluation of acupuncture;evaluation of acupuncture tolerance;compliance observation;Blind evaluation;

Countries

China

Contacts

Public ContactLu Yonghui

Xiyuan Hospital, Chinese Academy of traditional Chinese Medicine

yhlu2008@sina.com+86 13521776025

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026